Skip to content

HSCS

HeartSciences Inc.

NASDAQ · Healthcare · Medical - Devices · US

$3.14
+6.44%
Ask drillr

Income statement

MetricTTM2026202520252024
Revenue
Total Revenue4.5K4.3K4.3K4.3K18.6K
Cost of Revenue136.0K133.1K133.1K129.8K101.2K
Gross Profit(131.4K)(128.8K)(128.8K)(125.5K)(82.6K)
Operating Expenses
R&D Expense905.6M2.8B2.8B4.4M2.9M
SG&A Expense2.0B5.6B5.6B3.8M3.3M
General & Admin Expense—————
Selling & Marketing Expense—————
Other Expenses(2.9B)(8.4B)(8.4B)——
Total Operating Expenses9.3M8.3M8.3M8.2M6.2M
Cost and Expenses9.5M8.4M8.4M8.4M6.3M
Operating Income (EBIT)(9.5M)(8.4M)(8.4M)(8.4M)(6.3M)
Non-Operating
Interest Income(806.00)——87.8K—
Interest Expense804.6K753.0K753.0K500.5K354.1K
Net Interest Income(805.4K)(753.0K)(753.0K)(412.7K)(354.1K)
Other Non-Op Income/Expense(781.4K)(729.0K)(729.0K)(412.7K)(299.4K)
Non-Operating Income (excl Interest)(7.4K)———(54.6K)
EBT (Pre-Tax Income)(10.3M)(9.1M)(9.1M)(8.8M)(6.6M)
Income Tax Expense—————
Bottom Line
Net Income(10.3M)(9.1M)(9.1M)(8.8M)(6.6M)
Earnings from Cont. Ops(10.3M)(9.1M)(9.1M)(8.8M)(6.6M)
Earnings from Discont. Ops—————
Bottom Line Net Income(10.3M)(9.1M)(9.1M)(8.8M)(6.6M)
Per Share
Basic EPS($3.20)($3.48)($3.48)($9.34)($18.74)
Diluted EPS($3.20)($3.48)($3.48)($9.34)($18.74)
Revenue Per Share$0.00$0.00$0.00$0.00$0.05
Shares
Basic Shares Outstanding3.7M2.6M2.6M938257352520
Diluted Shares Outstanding3.7M2.6M2.6M938257352520
Profitability Metrics
EBITDA(9.3M)(8.3M)(8.3M)(8.2M)(6.2M)
D&A134.2K131.3K131.3K128.0K95.1K
EBIT(9.5M)(8.4M)(8.4M)(8.4M)(6.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026